Effect of Serenoa repens (Permixon®) on the expression of inflammation-related genes: analysis in primary cell cultures of human prostate carcinoma (Q39180649)

From Wikidata

Jump to navigation Jump to search

scientific article published on 14 March 2013

Language	Label	Description	Also known as
English	Effect of Serenoa repens (Permixon®) on the expression of inflammation-related genes: analysis in primary cell cultures of human prostate carcinoma	scientific article published on 14 March 2013

Statements

scholarly article

1 reference

Europe PubMed Central

9 September 2017

Effect of Serenoa repens (Permixon®) on the expression of inflammation-related genes: analysis in primary cell cultures of human prostate carcinoma (English)

1 reference

Europe PubMed Central

9 September 2017

object named as

Serenoa repens

1 reference

based on heuristic

inferred from title

Vincenzo Gentile

8

1 reference

Europe PubMed Central

9 September 2017

Alessandro Sciarra

9

1 reference

Europe PubMed Central

9 September 2017

author name string

Ida Silvestri

1

1 reference

Europe PubMed Central

9 September 2017

Susanna Cattarino

2

1 reference

Europe PubMed Central

9 September 2017

AnnaMaria Aglianò

3

1 reference

Europe PubMed Central

9 September 2017

Chiara Nicolazzo

4

1 reference

Europe PubMed Central

9 September 2017

Susanna Scarpa

5

1 reference

Europe PubMed Central

9 September 2017

Stefano Salciccia

6

1 reference

Europe PubMed Central

9 September 2017

Luigi Frati

7

1 reference

Europe PubMed Central

9 September 2017

publication date

14 March 2013

1 reference

Europe PubMed Central

9 September 2017

Journal of Inflammation

1 reference

Europe PubMed Central

9 September 2017

10

1 reference

Europe PubMed Central

9 September 2017

11

1 reference

Europe PubMed Central

9 September 2017

https://scigraph.springernature.com/pub.10.1186/1476-9255-10-11

0 references

The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653817

10 September 2017

Prostate cancer as a model for tumour immunotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653817

10 September 2017

Polymorphisms of pro-inflammatory genes and prostate cancer risk: a pharmacogenomic approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653817

10 September 2017

Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653817

10 September 2017

Inflammation, infection, and prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653817

10 September 2017

Inflammation and chronic prostatic diseases: evidence for a link?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653817

10 September 2017

Failure of apoptosis and activation on NFkappaB by celecoxib and aspirin in lung cancer cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653817

10 September 2017

Nuclear factor-kappaB in cancer development and progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653817

10 September 2017

Primary cell cultures as models of prostate cancer development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653817

10 September 2017

Molecular insights into prostate cancer progression: the missing link of tumor microenvironment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653817

10 September 2017

Are primary cultures realistic models of prostate cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653817

10 September 2017

Apoptotic pathways: paper wraps stone blunts scissors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653817

10 September 2017

Caspases: enemies within

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653817

10 September 2017

Effect of the lipidosterolic extract of Serenoa repens (Permixon) and its major components on basic fibroblast growth factor-induced proliferation of cultures of human prostate biopsies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653817

10 September 2017

c-Src dependency of NSAID-induced effects on NF-κB-mediated apoptosis in colorectal cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653817

10 September 2017

Anticancer activity of a cyclooxygenase inhibitor, CX9051, in human prostate cancer cells: the roles of NF-kappaB and crosstalk between the extrinsic and intrinsic apoptotic pathways

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653817

14 September 2017

Lipido-sterolic extract of Serenoa repens (LSESr, Permixon) treatment affects human prostate cancer cell membrane organization.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653817

14 September 2017

The proapoptotic effects of sulindac, sulindac sulfone and indomethacin are mediated by nucleolar translocation of the RelA(p65) subunit of NF-kappaB.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653817

14 September 2017

Saw Palmetto induces growth arrest and apoptosis of androgen-dependent prostate cancer LNCaP cells via inactivation of STAT 3 and androgen receptor signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653817

14 September 2017

Gemcitabine-induced apoptosis in 5637 cell line: an in-vitro model for high-risk superficial bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653817

14 September 2017

Effect of permixon on human prostate cell growth: lack of apoptotic action

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653817

14 September 2017

Effects of the lipidosterolic extract of Serenoa repens (Permixon) on human prostatic cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653817

25 September 2017

BPH and inflammation: pharmacological effects of Permixon on histological and molecular inflammatory markers. Results of a double blind pilot clinical assay.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653817

21 August 2018

Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653817

21 August 2018

Temporal pattern of NFkappaB activation influences apoptotic cell fate in a stimuli-dependent fashion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3653817

21 August 2018

Evidence that Serenoa repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23497174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On chromosomal instability: what is the karyotype of your 32D CI3 cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/23497174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of the lipidic lipidosterolic extract of Serenoa repens (Permixon) on the ionophore A23187-stimulated production of leukotriene B4 (LTB4) from human polymorphonuclear neutrophils

1 reference

https://pubmed.ncbi.nlm.nih.gov/23497174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The selectivity and specificity of the actions of the lipido-sterolic extract of Serenoa repens (Permixon) on the prostate

1 reference

https://pubmed.ncbi.nlm.nih.gov/23497174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of apoptosis and inhibition of cell proliferation by the lipido-sterolic extract ofSerenoa repens (LSESr, Permixon�) in benign prostatic hyperplasia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23497174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Binding of permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate

1 reference

https://pubmed.ncbi.nlm.nih.gov/23497174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serenoa repens (Permixon): a 5alpha-reductase types I and II inhibitor-new evidence in a coculture model of BPH

1 reference

https://pubmed.ncbi.nlm.nih.gov/23497174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1476-9255-10-11

1 reference

Europe PubMed Central

9 September 2017

1 reference

Europe PubMed Central

9 September 2017

1 reference

Europe PubMed Central

9 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39180649&oldid=1811922201"